CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment, 32753 [2016-12224]
Download as PDF
<![CDATA[
Federal Register / Vol. 81, No. 100 / Tuesday, May 24, 2016 / Notices
accordance with law, the Receiver will
be making a final dividend payment to
proven creditors.
Based upon the foregoing, the
Receiver has determined that the
continued existence of the receivership
will serve no useful purpose.
Consequently, notice is given that the
receivership shall be terminated, to be
effective no sooner than thirty days after
the date of this Notice. If any person
wishes to comment concerning the
termination of the receivership, such
comment must be made in writing and
sent within thirty days of the date of
this Notice to: Federal Deposit
Insurance Corporation, Division of
Resolutions and Receiverships,
Attention: Receivership Oversight
Department 34.6, 1601 Bryan Street,
Dallas, TX 75201.
No comments concerning the
termination of this receivership will be
considered which are not sent within
this time frame.
Date: May 19, 2016.
Federal Deposit Insurance Corporation.
Robert E. Feldman,
Executive Secretary.
FEDERAL ELECTION COMMISSION
Sunshine Act Meetings
Federal Election Commission.
& TIME: Thursday, May 19, 2016
at 10:00 a.m.
PLACE: 999 E Street, NW., Washington,
DC (ninth floor).
STATUS: This meeting will be open to
the public.
Federal Register Notice of Previous
Announcement—81 FR 30304.
The Following Item Was Also
Discussed: REG 2014–01 Outline of
Draft NPRM Implementing Party
Segregated Accounts.
PERSON TO CONTACT FOR INFORMATION:
Judith Ingram, Press Officer, Telephone:
(202) 694–1220.
AGENCY:
DATE
Shawn Woodhead Werth,
Secretary and Clerk of the Commission.
[FR Doc. 2016–12298 Filed 5–20–16; 11:15 am]
BILLING CODE 6715–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2016–12180 Filed 5–23–16; 8:45 am]
BILLING CODE 6714–01–P
Centers for Disease Control and
Prevention
FEDERAL ELECTION COMMISSION
CDC/HRSA Advisory Committee on
HIV, Viral Hepatitis and STD Prevention
and Treatment
Sunshine Act Meetings
Federal Election Commission.
& TIME: Thursday, May 26, 2016
at 10:00 a.m.
PLACE: 999 E Street NW., Washington,
DC (Ninth Floor).
STATUS: This meeting will be open to
the public.
ITEMS TO BE DISCUSSED:
Proposed Statement of Policy Regarding
the Public Disclosure of Closed
Enforcement Files
Management and Administrative
Matters
Individuals who plan to attend and
require special assistance, such as sign
language interpretation or other
reasonable accommodations, should
contact Shawn Woodhead Werth,
Secretary and Clerk, at (202) 694–1040,
at least 72 hours prior to the meeting
date.
PERSON TO CONTACT FOR INFORMATION:
Judith Ingram, Press Officer, Telephone:
(202) 694–1220.
AGENCY:
sradovich on DSK3TPTVN1PROD with NOTICES
DATE
Shawn Woodhead Werth,
Secretary and Clerk of the Commission.
[FR Doc. 2016–12248 Filed 5–20–16; 11:15 am]
BILLING CODE 6715–01–P
VerDate Sep<11>2014
17:24 May 23, 2016
Jkt 238001
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC) and the
Health Resources and Services
Administration (HRSA) announce the
following committee meeting.
Times and Dates: 8:30 a.m.–5:30 p.m.,
EDT, June 14, 2016; 8:30 a.m.–3:00 p.m.,
EDT, June 15, 2016.
Place: CDC Corporate Square,
Building 8, Conference Room 1–ABC, 8
Corporate Boulevard, Atlanta, Georgia
30329, Telephone: (404) 639–8317. The
meeting is also accessible by
teleconference. Toll-free number +1
(877) 603–4228, Participant code:
42598858.
Status: Open to the public, limited
only by the space available. The meeting
room will accommodate approximately
100 people.
Purpose: This Committee is charged
with advising the Director, CDC and the
Administrator, HRSA, regarding
activities related to prevention and
control of HIV/AIDS, Viral Hepatitis and
other STDs, the support of health care
services to persons living with HIV/
AIDS, and education of health
professionals and the public about HIV/
AIDS, Viral Hepatitis and other STDs.
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
32753
Matters For Discussion: Agenda items
include: (1) Syphilis among Men Who
Have Sex with Men (MSM) and
Congenital Syphilis; (2) Update on
CDC’s Medical Monitoring Project; (3)
Discussion on Infectious Diseases
prevention for people who inject drugs
(PWID); (4) Findings of the Institute of
Medicine Committee on A National
Strategy for the Elimination of Hepatitis
B and C: Feasible elimination goals and
possible factors critical for success; and
(5) Updates from Workgroups.
Agenda items are subject to change as
priorities dictate.
Contact Person For More Information:
Margie Scott-Cseh, CDC, National
Center for HIV/AIDS, Viral Hepatitis,
STD, and TB Prevention, 1600 Clifton
Road NE., Mailstop E–07, Atlanta,
Georgia 30333; telephone (404) 639–
8317.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
Notices pertaining to announcements of
meetings and other committee
management activities, for both the CDC
and the Agency for Toxic Substances
and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention (CDC).
[FR Doc. 2016–12224 Filed 5–23–16; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Subcommittee for Dose
Reconstruction Reviews (SDRR),
Advisory Board on Radiation and
Worker Health (ABRWH or the
Advisory Board), National Institute for
Occupational Safety and Health
(NIOSH)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting for the
aforementioned subcommittee:
Time and Date
10:30 a.m.–5:00 p.m., EDT, June 14,
2016
Place: Audio Conference Call via FTS
Conferencing.
Status: Open to the public, but
without a public comment period. The
public is welcome to submit written
comments in advance of the meeting, to
the contact person below. Written
E:\FR\FM\24MYN1.SGM
24MYN1
]]>Agencies
[Federal Register Volume 81, Number 100 (Tuesday, May 24, 2016)]
[Notices]
[Page 32753]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-12224]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD
Prevention and Treatment
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) and the Health Resources and Services Administration
(HRSA) announce the following committee meeting.
Times and Dates: 8:30 a.m.-5:30 p.m., EDT, June 14, 2016; 8:30
a.m.-3:00 p.m., EDT, June 15, 2016.
Place: CDC Corporate Square, Building 8, Conference Room 1-ABC, 8
Corporate Boulevard, Atlanta, Georgia 30329, Telephone: (404) 639-8317.
The meeting is also accessible by teleconference. Toll-free number +1
(877) 603-4228, Participant code: 42598858.
Status: Open to the public, limited only by the space available.
The meeting room will accommodate approximately 100 people.
Purpose: This Committee is charged with advising the Director, CDC
and the Administrator, HRSA, regarding activities related to prevention
and control of HIV/AIDS, Viral Hepatitis and other STDs, the support of
health care services to persons living with HIV/AIDS, and education of
health professionals and the public about HIV/AIDS, Viral Hepatitis and
other STDs.
Matters For Discussion: Agenda items include: (1) Syphilis among
Men Who Have Sex with Men (MSM) and Congenital Syphilis; (2) Update on
CDC's Medical Monitoring Project; (3) Discussion on Infectious Diseases
prevention for people who inject drugs (PWID); (4) Findings of the
Institute of Medicine Committee on A National Strategy for the
Elimination of Hepatitis B and C: Feasible elimination goals and
possible factors critical for success; and (5) Updates from Workgroups.
Agenda items are subject to change as priorities dictate.
Contact Person For More Information: Margie Scott-Cseh, CDC,
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention,
1600 Clifton Road NE., Mailstop E-07, Atlanta, Georgia 30333; telephone
(404) 639-8317.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register Notices pertaining to
announcements of meetings and other committee management activities,
for both the CDC and the Agency for Toxic Substances and Disease
Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention (CDC).
[FR Doc. 2016-12224 Filed 5-23-16; 8:45 am]
BILLING CODE 4163-18-P
